Search Results 2711-2720 of 14525 for Lupus

  1. A Phase 2a Study Of TPN-101 In Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

    The primary objective of this study is to asssess the safety and tolerability of TPN-101 in patients with progressive supranuclear palsy (PSP). Participation ...

  2. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  3. A Study To Establish A Parkinson’s Disease (PD) Cohort Using The Parkinson’s Progression Markers Initiative (PPMI) - Mayo Clinic

    The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic ...

  4. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

    A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety ...

  5. Study of mouse gut microbiome may provide clues to how cancer develops in humans - Mayo Clinic News Network

    ROCHESTER, Minn. ― A study of the mouse gut microbiome led by researchers from Mayo Clinic may shed light on how cancerous tumors develop and progress in ...

  6. Publications - Anuradha Luke, M.D. - Mayo Clinic

    McCoy RG, Juntunen MB, Ridgeway JL, Hentz JG, Glasgow AE, Liedl C, Murley BM, Warrington CE, Sundt WJ, Krpata TS, Haugo OA, Lampman MA, Fink AL, ...

  7. Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Study Of HPN536 In Patients With Advanced Cancers Associated With Mesothelin Expression - Mayo Clinic

    To assess the safety and tolerability at increasing dose levels of HPN536 in successive cohorts of patients with epithelial ovarian, fallopian tube, or primary ...

  9. New and novel treatments for hyperlipidemia - Mayo Clinic

    Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...

  10. Systemic Synuclein Sampling Study (S4) - Clinical Trials

    About this study. The purpose of this study is to measure alpha-synuclein in peripheral body tissues and fluids in Parkinson's disease (PD).